Influence of a platelet-activating factor antagonist on severe pancreatitis in two experimental models (Q67960426)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1460331%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

title

Influence of a platelet-activating factor antagonist on severe pancreatitis in two experimental models (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1460331%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

author name string

U. Leonhardt

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1460331

28 September 2022

A. Fayyazzi

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1460331

28 September 2022

F. Seidensticker

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1460331

28 September 2022

F. Stöckmann

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1460331

28 September 2022

H. D. Söling

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1460331

28 September 2022

W. Creutzfeldt

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1460331

28 September 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1460331

28 September 2022

publication date

1 October 1992

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1460331%20AND%20SRC:MED&resulttype=core&format=json

International Journal of Pancreatology

19 September 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1460331%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

volume

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1460331%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1460331%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

page(s)

161-166

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1460331%20AND%20SRC:MED&resulttype=core&format=json

Effect of FOY-305 (camostate) on severe acute pancreatitis in two experimental animal models

19 September 2019

cites work

1 reference

12 December 2020

Influence of the CCK-antagonist loxiglumide on bile-induced experimental pancreatitis

1 reference

12 December 2020

Plasma levels of the lyso-derivative of platelet-activating factor in acute severe systemic illness

1 reference

12 December 2020

Evaluation of PAF antagonists using human neutrophils in a microtiter plate assay

1 reference

12 December 2020

Camostate (FOY-305) improves the therapeutic effect of peritoneal lavage on taurocholate induced pancreatitis

1 reference

12 December 2020

Therapeutic regimens in acute experimental hemorrhagic pancreatitis. Effects of hydration, oxygenation, peritoneal lavage, and a potent protease inhibitor

1 reference

12 December 2020

Biological effects of the orally active platelet activating factor receptor antagonist SDZ 64-412.

1 reference

12 December 2020

Acute hemorrhagic pancreatic necrosis in mice. Intraparenchymal activation of zymogens, and other enzyme changes in pancreas and serum

1 reference

12 December 2020

Effect of camostate administration for two weeks on experimental pancreatitis in mice and rats

1 reference

12 December 2020

Use of WEB 2086 and WEB 2170 as platelet-activating factor antagonists

1 reference

12 December 2020

When should treatment of acute experimental pancreatitis be started? The early phase of bile-induced acute pancreatitis

1 reference

12 December 2020

Synthesis of 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine (platelet-activating factor) in exocrine glands and its control by secretagogues

1 reference

12 December 2020

Pharmacological actions of WEB 2086, a new specific antagonist of platelet activating factor.

1 reference

12 December 2020

Experimental acute pancreatitis induced by platelet activating factor in rabbits

1 reference

12 December 2020

Perspectives in platelet-activating factor research

1 reference

12 December 2020

Acetylcholine-like effects of 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine ('platelet-activating factor') and its analogues in exocrine secretory glands

1 reference

12 December 2020

The effect of platelet activating factor antagonist (BN 52021) on cerulein-induced acute pancreatitis with reference to oxygen radicals

1 reference

12 December 2020

PAF increases vascular permeability in selected tissues: effect of BN-52021 and L-655,240.

1 reference

12 December 2020

Pharmacologic activity of bepafant (WEB 2170), a new and selective hetrazepinoic antagonist of platelet activating factor

1 reference

12 December 2020

Acute hemorrhagic pancreatitis (massive necrosis) with fat necrosis induced in mice by DL-ethionine fed with a choline-deficient diet

1 reference

12 December 2020

Immune complex induced pancreatitis: effect of BN 52021, a selective antagonist of platelet-activating factor.

1 reference

12 December 2020

Influence of buprenorphine on acute experimental pancreatitis

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF02924640

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1460331

28 September 2022

1 reference